News New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Related Stories Mobile Tech News Durabook Announces “Vanguard Partner Program” Enrichment to Channel Partners Program News Home games nearly double the crowd: World Cup WiFi data shows what the quarter final is worth to UK pubs, so Purple is dressing their WiFi in the England flag for free News BeautyPlus Launches AI-Powered Freeform Collage Maker for Photos and Videos News iPower Secures $2.0 Million Growth Capital to Advance AI, Supply Chain Infrastructure and Other Strategic Initiatives News Insignary Closes SBOM Accuracy Gap With Binary-Level Clarity for Regulatory Risk News A Big Advance Measuring Military Vocational Aptitude and Cognitive Resilience comes from “Brain Games”
